nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced breast cancer: new imaging techniques for detection of metastases
|
Schoellnast, Helmut |
|
2012 |
5 |
2 |
p. 129-133 |
artikel |
2 |
Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)
|
Peck-Radosavljevic, Markus |
|
2012 |
5 |
2 |
p. 161-162 |
artikel |
3 |
Breast cancer—advanced stage: “cure—still a long way to go?”
|
Stöger, Herbert |
|
2012 |
5 |
2 |
p. 85-86 |
artikel |
4 |
Breast cancer: is there a need for biopsy of metastases?
|
Zagouri, Flora |
|
2012 |
5 |
2 |
p. 125-128 |
artikel |
5 |
Cellular immunotherapy for cancer. Past, present, future
|
Spyridonidis, Alexandros |
|
2012 |
5 |
2 |
p. 81-84 |
artikel |
6 |
Clinical practice guidelines in oncology—achievements and challenges
|
Gastl, Günther |
|
2012 |
5 |
2 |
p. 87-89 |
artikel |
7 |
Evolving strategies to overcome endocrine resistance in breast cancer
|
Hubalek, Michael |
|
2012 |
5 |
2 |
p. 105-109 |
artikel |
8 |
Highlights in the adjuvant treatment of colon cancer from annual meetings 2011
|
Resch, Gudrun |
|
2012 |
5 |
2 |
p. 163-166 |
artikel |
9 |
Immunotherapeutic approaches targeting prostate cancer and its microenvironment
|
Zeiser, Robert |
|
2012 |
5 |
2 |
p. 94-97 |
artikel |
10 |
Immunotherapeutic approaches targeting prostate cancer and its microenvironment
|
Zeiser, Robert |
|
|
5 |
2 |
p. 94-97 |
artikel |
11 |
Immunotherapy for nonsmall-cell lung cancer
|
Belalcazar, Astrid |
|
2012 |
5 |
2 |
p. 90-93 |
artikel |
12 |
Immunotherapy for nonsmall-cell lung cancer
|
Belalcazar, Astrid |
|
|
5 |
2 |
p. 90-93 |
artikel |
13 |
Interventional therapy for symptomatic bronchial carcinoma
|
Geltner, Christian |
|
2012 |
5 |
2 |
p. 149-153 |
artikel |
14 |
Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?
|
Petrausch, Ulf |
|
2012 |
5 |
2 |
p. 154-156 |
artikel |
15 |
Lung cancer screening: current evidence and recommendations
|
Mark, Michael |
|
2012 |
5 |
2 |
p. 144-148 |
artikel |
16 |
Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders
|
Tsirigotis, Panagiotis D. |
|
2012 |
5 |
2 |
p. 98-100 |
artikel |
17 |
Recent advances and future challenges in the treatment of upper gastrointestinal malignancies
|
Koeberle, Dieter |
|
2012 |
5 |
2 |
p. 157-160 |
artikel |
18 |
Sjögren syndrome complicated with hairy-cell leukemia: a case-based review
|
Bayat, Noushin |
|
2012 |
5 |
2 |
p. 141-143 |
artikel |
19 |
Surgical removal of the primary?—The role it plays in stage IV breast cancer
|
Fitzal, Florian |
|
2012 |
5 |
2 |
p. 116-118 |
artikel |
20 |
The role of biomarkers in the choice of therapy in breast cancer
|
Mlineritsch, Brigitte |
|
2012 |
5 |
2 |
p. 101-104 |
artikel |
21 |
The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer
|
Lőcsei, Zoltán |
|
2012 |
5 |
2 |
p. 119-124 |
artikel |
22 |
Treatment outcome in AML: a single-centre experience in an unselected patient cohort
|
Strasser-Weippl, Kathrin |
|
2012 |
5 |
2 |
p. 134-140 |
artikel |
23 |
What’s new in metastatic breast cancer?
|
Bartsch, Rupert |
|
2012 |
5 |
2 |
p. 110-115 |
artikel |